中国医药导报
中國醫藥導報
중국의약도보
CHINA MEDICAL HERALD
2015年
11期
46-49
,共4页
方永煌%岑柏宏%陈瑞晗%曹静桦%黄国杰%梁燕玲%董艳芬
方永煌%岑柏宏%陳瑞晗%曹靜樺%黃國傑%樑燕玲%董豔芬
방영황%잠백굉%진서함%조정화%황국걸%량연령%동염분
天然活性成分%抗心律失常%研究进展
天然活性成分%抗心律失常%研究進展
천연활성성분%항심률실상%연구진전
Natural active ingredients%Antiarrhythmic%Research progress
心律失常是心血管领域的常见病、多发病。2013年3月世界卫生组织报道,2008年死于心脑血管疾病者高达1730万,而到2030年将增至2330万。其中心脏性猝死占40%~50%,而大多数心脏性猝死由心律失常所引发,故抗心律失常新药的研发刻不容缓。近几年化学抗心律药物的研发渐入瓶颈,天然药物抗心律失常的价值重新得到世界的关注。目前天然药物抗心律失常活性成分多为生物碱类、黄酮类、皂苷类。本研究通过综合分析已报道的相关文献,概括近几年抗心律失常的天然药物活性成分研究进展,为天然药物活性成分的进一步研究提供依据。
心律失常是心血管領域的常見病、多髮病。2013年3月世界衛生組織報道,2008年死于心腦血管疾病者高達1730萬,而到2030年將增至2330萬。其中心髒性猝死佔40%~50%,而大多數心髒性猝死由心律失常所引髮,故抗心律失常新藥的研髮刻不容緩。近幾年化學抗心律藥物的研髮漸入瓶頸,天然藥物抗心律失常的價值重新得到世界的關註。目前天然藥物抗心律失常活性成分多為生物堿類、黃酮類、皂苷類。本研究通過綜閤分析已報道的相關文獻,概括近幾年抗心律失常的天然藥物活性成分研究進展,為天然藥物活性成分的進一步研究提供依據。
심률실상시심혈관영역적상견병、다발병。2013년3월세계위생조직보도,2008년사우심뇌혈관질병자고체1730만,이도2030년장증지2330만。기중심장성졸사점40%~50%,이대다수심장성졸사유심률실상소인발,고항심률실상신약적연발각불용완。근궤년화학항심률약물적연발점입병경,천연약물항심률실상적개치중신득도세계적관주。목전천연약물항심률실상활성성분다위생물감류、황동류、조감류。본연구통과종합분석이보도적상관문헌,개괄근궤년항심률실상적천연약물활성성분연구진전,위천연약물활성성분적진일보연구제공의거。
Arrhythmias are common in the field of cardiovascular disease. In March 2013, World Health Organization reported that, in 2008 the population who died of cardiovascular disease has been as high as 17.3 million, and by 2030 will increase to 23.3 million. Sudden cardiac death accounts for about 40%-50%, while the majority of sudden cardiac death caused by arrhythmia, so the development of new drugs antiarrhythmic is urgent. In recent years, the development of chemical antiarrhythmic drugs getting into the bottleneck, the value of natural antiarrhythmic drug has gotten the world's attention again. At present, the active ingredient of natural antiarrhythmic drugs mainly are alkaloids, flavonoids, saponins. By a comprehensive analysis of the reported literature, the article generalizes the research progress which is about the active ingredient of natural antiarrhythmic drug in nearly a decade, in order to provide certain basis for further study on the active ingredient of natural drugs.